Literature DB >> 6697117

Randomized prospective trial of Roux-en-Y duodenal diversion versus fundoplication for severe reflux oesophagitis.

G F Washer, M W Gear, B L Dowling, E W Gillison, C M Royston, J Spencer.   

Abstract

It is not widely recognized that duodenal contents are implicated in the causation of severe reflux oesophagitis and stricture formation in patients with hiatus hernia. In a randomized prospective trial, including only patients with severe oesophageal changes, standard Nissen fundoplication has been compared with antrectomy and Roux-en-Y reconstruction. Twenty-two patients were randomized to each group. The 42 surviving trial patients have been followed for an average period of over 5 years. Good results (Visick I or II) have been achieved in 91 per cent of 22 patients having antrectomy and Roux-en-Y anastomosis (Group B), compared with 65 per cent of 20 patients surviving after Nissen fundoplication (Group A). Poor results (Visick III or IV) seen in seven patients (35 per cent) in group A were almost all associated with failure of fundoplication to stop reflux. Two of these patients have subsequently had antrectomy and Roux-en-Y reconstruction with excellent results. Antrectomy with Roux-en-Y gastrojejunostomy appears to be superior to a standard anti-reflux procedure as primary surgical treatment in these patients. The technique is recommended: where the patient has a fixed irreducible hiatus hernia; where previous surgery at the hiatus has failed and rendered reoperation hazardous.

Entities:  

Mesh:

Year:  1984        PMID: 6697117     DOI: 10.1002/bjs.1800710303

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  13 in total

1.  Early and late results of the acid suppression and duodenal diversion operation in patients with barrett's esophagus: analysis of 210 cases.

Authors:  Attila Csendes; Patricio Burdiles; Italo Braghetto; Owen Korn; Juan Carlos Díaz; Jorge Rojas
Journal:  World J Surg       Date:  2002-03-01       Impact factor: 3.352

2.  What is the place of antrectomy with Roux-en-Y in the treatment of reflux disease? Experience with 83 total duodenal diversions.

Authors:  F Fekete; D Pateron
Journal:  World J Surg       Date:  1992 Mar-Apr       Impact factor: 3.352

3.  Roux-en-Y reconstruction for failed fundoplication.

Authors:  Konstantinos I Makris; Tommy Lee; Sumeet K Mittal
Journal:  J Gastrointest Surg       Date:  2009-09-02       Impact factor: 3.452

4.  Perioperative outcomes of surgical procedures for symptomatic fundoplication failure: a retrospective case-control study.

Authors:  Sandeepa Musunuru; Jon C Gould
Journal:  Surg Endosc       Date:  2011-11-04       Impact factor: 4.584

5.  [Hiatal hernia and reflux disease--long-term results following fundoplication and consequences in therapeutic failures].

Authors:  C Ackermann; L Margreth; C Muller; F Harder
Journal:  Langenbecks Arch Chir       Date:  1987

6.  The role of short-limb Roux-en-Y reconstruction for failed antireflux surgery: a single-center 5-year experience.

Authors:  Konstantinos I Makris; Aru Panwar; Brittany L Willer; Anah Ali; Katherine L Sramek; Tommy H Lee; Sumeet K Mittal
Journal:  Surg Endosc       Date:  2011-11-02       Impact factor: 4.584

7.  Is there an association between failed antireflux procedures and delayed gastric emptying?

Authors:  G J Maddern; G G Jamieson; B E Chatterton; P J Collins
Journal:  Ann Surg       Date:  1985-08       Impact factor: 12.969

8.  Duodenal diversion with vagotomy and antrectomy for severe or recurrent reflux oesophagitis and stricture: an alternative to operation at the hiatus.

Authors:  G F Washer; M W Gear; B L Dowling; E W Gillison; C M Royston; J Spencer
Journal:  Ann R Coll Surg Engl       Date:  1986-07       Impact factor: 1.891

9.  [Reconstruction of the gastroesophageal sphincter in reflux disease].

Authors:  F Kümmerle; J Grönniger
Journal:  Langenbecks Arch Chir       Date:  1985

10.  Vagotomy, antrectomy, and Roux-en-Y diversion for complex reoperative gastroesophageal reflux disease.

Authors:  F H Ellis; S P Gibb
Journal:  Ann Surg       Date:  1994-10       Impact factor: 12.969

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.